Showing results (71-80 of 606) with videos related to
Sort By:
Pageof 61
Frontiers in Bioscience : a Journal and Virtual Library|May 9, 2007
Genetically-engineered animals as research models for atherosclerosis: their use for the characterization of PPAR agonists in the treatment of cardiometabolic disordersCatherine Fievet, Jean-Charles Fruchart, Bart StaelsArteriosclerosis, Thrombosis, and Vascular Biology|March 8, 2008
Regulation of macrophage functions by PPAR-alpha, PPAR-gamma, and LXRs in mice and menElena Rigamonti, Giulia Chinetti-Gbaguidi, Bart StaelsTrends in Endocrinology and Metabolism: TEM|August 12, 2022
Immune-metabolic interactions in homeostasis and the progression to NASHJoanne A Hoogerland, Bart Staels, David DombrowiczAtherosclerosis|November 25, 2024
Liver metabolism in human MASLD: A review of recent advancements using human tissue metabolomicsEmily Flam, Joel T Haas, Bart StaelsNature Reviews. Cardiology|November 5, 2014
Macrophage subsets in atherosclerosisGiulia Chinetti-Gbaguidi, Sophie Colin, Bart StaelsCellular and Molecular Life Sciences : CMLS|December 17, 2014
Nuclear bile acid signaling through the farnesoid X receptorClaire Mazuy, Audrey Helleboid, Bart Staels, et al.Nature Reviews. Endocrinology|September 17, 2016
PPARs in obesity-induced T2DM, dyslipidaemia and NAFLDBarbara Gross, Michal Pawlak, Philippe Lefebvre, et al.Journal of Lipid Research|May 3, 2012
Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular diseaseGeoffrey Porez, Janne Prawitt, Barbara Gross, et al.Diabetes Care|August 6, 2011
Effects of the new dual PPAR α/δ agonist GFT505 on lipid and glucose homeostasis in abdominally obese patients with combined dyslipidemia or impaired glucose metabolismBertrand Cariou, Yassine Zaïr, Bart Staels, et al.Gut|June 11, 2024
Nuclear receptors: pathophysiological mechanisms and drug targets in liver diseaseVanessa Dubois, Philippe Lefebvre, Bart Staels, et al.Pageof 61